Ceramide is Involved in MPP+ -induced Cytotoxicity in Human Neuroblastoma Cells.
- Author:
Eun Joo NAM
1
;
Hye Sook LEE
;
Young Jae LEE
;
Wan Seok JOO
;
Sungho MAENG
;
Hye In IM
;
Chan Woong PARK
;
Yong Sik KIM
Author Information
1. Department of Pharmacology, Seoul National University College of Medicine and Neuroscience Research Institute, Medical Research Center, Seoul, Korea. kimysu@plaza.snu.ac.kr
- Publication Type:Original Article
- Keywords:
Dopaminergic neuroblastoma;
MPP+;
Sphingomyelinase;
Ceramide-activated protein phosphatase
- MeSH:
Cell Death;
Humans*;
Neuroblastoma*;
Okadaic Acid;
Sphingomyelin Phosphodiesterase
- From:The Korean Journal of Physiology and Pharmacology
2002;6(6):281-286
- CountryRepublic of Korea
- Language:English
-
Abstract:
To understand the cytotoxic mechanism of MPP+, we examined the involvement of ceramide in MPP+ -induced cytotoxicity to human neuroblastoma SH-SY5Y cells. When SH-SY5Y cells were exposed to MPP+, MPP+ induced dose-dependent cytotoxicity accompanied by 2-fold elevation of intracellular ceramide levels in SH-SY5Y cells. Three methods were used to test the hypothesis that the elevated intracellular ceramide is related to MPP+ -induced cytotoxicity: C2-ceramide was directly applied to cells, sphingomyelinase (SMase) was exogenously added, and oleoylethanolamine (OE) was used to inhibit degradation of ceramide. Furthermore, inhibition of ceramide-activated protein phosphatase (CAPP), the effector of ceramide, using okadaic acid (OA) attenuated cell death but treatment of fumonisin B1, the ceramide synthase inhibitor, did not alter the cytotoxic effect of MPP+. Based on these, we suggest that the elevation of intracellular ceramide is one of the important mediators in MPP+ -induced cell death.
